All News about Annovis Bio Inc![]() ![]() ![]() ![]()
Annovis Bio Announces Positive FDA Feedback for Buntanetap Phase 3 Clinical Development in Parkinson's Disease
January 25, 2022
Via Newsfile
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via NewMediaWire
Topics
Lawsuit
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|